Alle episoder

A moderated panel of prominent female rheumatologists will discuss the challenges and successes in clinical practice and research that they encountere...

The ACR 2021 meeting has concluded. Dr. Jack Cush recants a few more great abstracts from this past weeks meeting.

Drs. Jack Cush and Martin Bergman gather to review the topic of treat-to-target (T2T) management in rheumatology.  Both will debate the pro's and con'...

Dr. Jack Cush discusses the evolution and future of telemedicine in rheumatology with the telemedicine guru - Dr. Alvin Wells

Dr. Jack Cush interviews Professor Edward Keystone, MD (from the University of Toronto) on the origins and science behind the 60/40/20 benchmark and o...

Panelists: Drs. Antoni Chan, Robert Chao, Rachel Tate, Sheila Reyes and Akhil Sood.

An Interview with Dr. Kaleb Michaud on Abstract 1158 from #ACR21

ALPN-303 - Dr. Pedro Castillo Dr. Castillo reports on abstract #1429 presented at the ACR21 annual meeting.

JAK Safety -- The Lowdown on Infection: Drs. Kevin Winthrop and Jonathan Kay Infections in ORAL Surveillance: Drs. Kevin Winthrop and Jonathan Kay I...

Spondyloarthritis Roundtable Rehash of ACR 2021

Giant Cell Arteritis and Polymyalgia Rheumatic Wrapup: Drs. Calabrese, Liew, Conway and Mackie

Reproductive Health in Rheumatic Diseases: Drs. Bermas, Buyon and Dao

The Expert Gout Panel with Drs. Neogi, Saag, Pillinger, Cush and O'Dell

Tofacitinib and Malignancy Risk: Dr. Seoyoung Kim Potpourri of Biosimilar Trials: Dr. Jonathan Kay Closing a Chapter: Interview with the 84th ACR Pr...

RheumNow Rheumatology Roundup- Drs.  Kavanaugh and Cush

TNF Inhibitor Panel Discussion- ACR21 Annual Meeting

Psoriatric Arthritis Panel Discussion- ACR21

RA Panel- Safety, Multimorbidities, Vaccination and the Weather

Glucocorticoids and CV risk in RA: Drs. Aurelie Najm and Jon Giles Might Tofacitinib Reduce Malignancy Risk with Patients with RA? Dr. Jonathan Kay ...

Diagnosing (Bad) VEXAS: The Experts Speak with Drs. Cush, Beck and Ferrada CV Risks and Gout T2T - An Interview with Dr. Seoyoung Kim, Kathryn Dao

Dr. Michelle Petri - Urine Proteome Advances: What Do They Mean? "Doctor, I Can Tell When It's Raining!" - Dr. Aurelie Najm NSAIDS Prevent Heart Att...

Sex, Age and Race/Ethnic Differences in Multimorbidity in Lupus: Drs. Duarte and Mehta Hospitalization Trends in Patients with Psoriatic Arthritis: D...

Uveitis in AxSpa: Dr. Sheila Reyes ACR Gold Medal Recipient: Dr. Stan Cohen Infection Risk in Offspring Exposed to Biologics: Dr. Rachel Tate Stero...

ACR21 Day 3 Recap- Polypharmacy, New Lupus Drugs, VEXAS, Safety Data

Dr. Janet Pope: RA Conundrums Drs Kathryn Dao, Una Makris and Raymond Yung: Caring for the Older Patient with Rheumatic Disease Dr. Arthur Kavanaugh...

Drs Jack Cush, Yuz Yusof, Bella Mehta, Olga Petryna, and Rachel Tate Auto-inflammatory Panel

The Respiratory Tract and RA with Drs. Sparks, McDermott and Kronzer Guselkumab Use Improves Anemia in Treatment of PsA: Dr. Robert Chao Ultra Low D...

Long Term Steroid Use in RA - Matters of the Heart: Dr. Mrinalini Dey Data on Existing SLE Medications, Patient Centered Outcomes, and Exercise: Dr. ...

Real Time Monitoring of Disease Activity? There's An App for That: Dr. Akhil Sood CBD and Opioids in Psoriatic Arthritis: Dr. Eric Ruderman Osteopor...

First JAKi Failure: What next? Dr. Aurelie Najm: RAPID3 in Psoriatic Arthritis: Dr. Meral El Ramahi Herpes Zoster and Rheumatoid Arthritis with Dr. ...